100,000 Genomes Project
Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test
Biocartis will lead commercialization in Europe as the exclusive distributor of the SeptiCyte Rapid test, while Immunexpress will lead commercialization of the test in the US.
Illumina, Genomics England Ink Deal to Sequence up to 300K People
The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
UK Genomic Analysis Firm Congenica Raises $10M
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.